are liraglutide and semaglutide the same Discovery Development of and Efficacy of the Glucagon-Like Peptide-1

doi: 10.1053/j.gastro.2011.02.018 7 KnudsenLBLauJ

Current medical guidance treats obesity as a chronic condition, and long-term or indefinite semaglutide use is considered appropriate for patients with ongoing obesity-related health conditions

Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Feature

Short answer: Service Members should avoid using compounded and investigational GLP-1 drugs as they pose severe risks to military health and readiness

These drugs, which mimic the GLP-1 hormone, help people lose substantially more weight than they typically would with diet and exercise alone